These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14533069)

  • 1. [Mucopolysaccharidosis type I in the Cuban population].
    Menéndez-Sainz C; Zaldívar-Muñoz C; González-Quevedo A
    Rev Neurol; 2003 Sep 16-30; 37(6):525-8. PubMed ID: 14533069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mucopolysaccharidosis: 20-year enzymatic diagnosis in Cuba].
    Menéndez-Sainz C; Gonzaléz-García S; Peña-Sánchez M; Zaldívar-Muñoz C; González-Quevedo A
    Rev Neurol; 2009 Nov 1-15; 49(9):458-62. PubMed ID: 19859885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.
    Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S
    Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucopolysaccharidosis type I: clinical and biochemical study.
    Bassyouni HT; Afifi HH; el-Awadi MK; Meguid NA
    East Mediterr Health J; 2000; 6(2-3):359-66. PubMed ID: 11556024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mucopolysaccharidosis type I: identification of alpha-L-iduronidase mutations in Tunisian families].
    Chkioua L; Khedhiri S; Jaidane Z; Ferchichi S; Habib S; Froissart R; Bonnet V; Chaabouni M; Dandana A; Jrad T; Limem H; Maire I; Abdelhedi M; Laradi S
    Arch Pediatr; 2007 Oct; 14(10):1183-9. PubMed ID: 17728118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.
    Stevenson RE; Howell RR; McKusick VA; Suskind R; Hanson JW; Elliott DE; Neufeld EF
    Pediatrics; 1976 Jan; 57(1):111-22. PubMed ID: 813180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
    Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
    Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent allelism of the Hurler, Scheie, and Hurler/Scheie syndromes.
    Mueller OT; Shows TB; Opitz JM
    Am J Med Genet; 1984 Jul; 18(3):547-56. PubMed ID: 6433708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
    Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ
    Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype.
    Scott HS; Litjens T; Hopwood JJ; Morris CP
    Hum Mutat; 1992; 1(2):103-8. PubMed ID: 1301196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype.
    Scott HS; Litjens T; Nelson PV; Brooks DA; Hopwood JJ; Morris CP
    Hum Mutat; 1992; 1(4):333-9. PubMed ID: 1301941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I Registry.
    Arn P; Wraith JE; Underhill L
    J Pediatr; 2009 Jun; 154(6):859-64.e3. PubMed ID: 19217123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hurler syndrome. Early diagnosis and successful enzyme replacement therapy: a new therapeutic approach. Case report].
    Dupont C; El Hachem C; Harchaoui S; Ribault V; Amiour M; Guillot M; Maire I; Froissart R; Guffon-Fouilhoux N
    Arch Pediatr; 2008 Jan; 15(1):45-9. PubMed ID: 18162380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical spectrum of alpha-L-iduronidase deficiency.
    Roubicek M; Gehler J; Spranger J
    Am J Med Genet; 1985 Mar; 20(3):471-81. PubMed ID: 3922223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
    Dekaban AS; Constantopoulos G; Herman MM; Steusing JK
    Arch Pathol Lab Med; 1976 May; 100(5):237-45. PubMed ID: 817693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic.
    Murphy AM; Lambert D; Treacy EP; O'Meara A; Lynch SA
    Arch Dis Child; 2009 Jan; 94(1):52-4. PubMed ID: 18463126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mucopolysaccharidoses and mucolipidoses.
    Kelly TE
    Clin Orthop Relat Res; 1976; (114):116-33. PubMed ID: 131015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
    Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
    J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations.
    Beesley CE; Meaney CA; Greenland G; Adams V; Vellodi A; Young EP; Winchester BG
    Hum Genet; 2001 Nov; 109(5):503-11. PubMed ID: 11735025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.